Community pharmacists' treatment patterns and counselling of acute diarrhea in children: A simulation-based

Mohammed Anaam1

  • 1Department of Pharmacy Practice, College of Pharmacy, Qassim University, Saudi Arabia.

PubMed

Insights

Community pharmacists in Yemen showed gaps in managing childhood diarrhea. They performed poorly in simulations, with inadequate assessment, counseling, and oral rehydration solution recommendations.

Area of Science:

  • Pharmacy practice
  • Pediatric health
  • Global health

Background:

  • Diarrhea is a major cause of child mortality globally, especially in resource-limited and conflict-affected regions like Yemen.
  • Acute diarrhea in children under five years remains a significant public health concern worldwide.

Purpose of the Study:

  • To evaluate community pharmacist treatment patterns for acute childhood diarrhea in Yemen.
  • To assess the quality of counseling provided by pharmacists regarding pediatric diarrhea management.

Main Methods:

  • A simulation-based cross-sectional study was conducted in Sana'a city, Yemen.
  • Community pharmacists were assessed using questionnaires and simulated client methods.
  • Evaluation focused on case assessment (age, diarrhea frequency, fever, blood/mucus), recommendations, and counseling.

Main Results:

  • Only 3% of pharmacists used all five key indicators during simulated client interactions, contrasting with 43% in questionnaires.
  • Oral rehydration solution (ORS) recommendations were inadequate in simulations (6% alone, 47% with other drugs), with 40% dispensing only antibiotics.
  • Counseling quality differed significantly, with 89% reporting adequate explanation in questionnaires versus only 36% in simulations.

Conclusions:

  • Community pharmacists in Yemen demonstrated insufficient evaluation of children with acute diarrhea in simulated scenarios.
  • Pharmacists provided inadequate dietary advice and insufficient recommendations for oral rehydration solution (ORS).
  • There was a notable discrepancy between pharmacists' self-reported practices and their actual performance in simulated patient encounters.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
117
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
205
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
159
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
191
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
126